Each major CIED manufacturer runs a proprietary remote monitoring ecosystem. The table below compares the four dominant platforms on factors that affect daily clinic operations. All platform descriptions come from publicly available manufacturer and payer documentation.
| Platform | Transmission Method | Patient Interface | Clinic Portal | Billing Support |
|---|---|---|---|---|
| Medtronic MyCareLink | Cellular/Bluetooth communicator, scheduled and patient-initiated | Dedicated bedside monitor or smartphone app | CareLink Network, Medtronic-device data only | Transmission logs available, no cross-vendor billing aggregation |
| Abbott myMerlin | Cellular communicator, automatic nightly and event-triggered | Merlin@home transmitter or myMerlin app | Merlin.net, Abbott-device data only | Transmission records available, no cross-vendor billing aggregation |
| Boston Scientific LATITUDE | Cellular/landline communicator, scheduled and alert-triggered | LATITUDE Communicator bedside unit | LATITUDE NXT, Boston Scientific-device data only | Transmission logs available, no cross-vendor billing aggregation |
| Biotronik Home Monitoring | Cellular CardioMessenger, continuous daily transmissions | CardioMessenger Smart device | BIOTRONIK Home Monitoring Service, Biotronik-device data only | Transmission records available, no cross-vendor billing aggregation |
Each portal works on its own, but none connects with the others. A clinic managing patients across all four manufacturers must maintain four separate logins, four alert queues, and four documentation workflows, with no unified billing layer.
Cardiology clinics managing CIED data from multiple manufacturers face fragmented data across device portals, the EHR, and scheduling and billing platforms, which causes duplicate manual data entry, stale clinical context, missed billing encounters, and higher audit risk.
The operational consequences compound quickly:
Core integration risks for clinics combining CIED data from multiple manufacturer portals include patient identity matching across MRNs and device serial numbers, alignment of encounter and order semantics for compliance, and ongoing change control as EHRs are updated.
Staff burnout follows quickly. Specialized device technicians, a scarce workforce, leave practices where administrative overload crowds out clinical work. Replacing a certified cardiac technician costs far more than the software that could have prevented the attrition. The solution to this multi-vendor chaos lies in adopting a platform that works with every major manufacturer.
See how Rhythm360 unifies your device data in a single, actionable dashboard.
Vendor-neutral platforms sit above the manufacturer layer and connect to every OEM. They ingest data from each OEM portal via API, HL7, XML, and PDF parsing, then normalize it into a single structured record without device replacement or manufacturer contract changes.
Rhythm360 maintains greater than 99.9% data transmissibility through redundant data feeds, computer vision OCR for unstructured PDF reports, and AI-powered gap extrapolation. If an OEM server goes offline, the redundant feed keeps data flowing. Clinicians base decisions on the most complete record available, not just the most recently synced one.
Real-time bi-directional EHR integration for CIED monitoring pulls demographics, diagnosis codes, medications, hospitalizations, and encounters on demand when transmissions arrive, while automatically writing back e-signed reports, discrete data, and billing information without manual intervention.
Rhythm360 uses AI-powered alert triage to filter non-actionable transmissions and surface clinically significant events in priority order. Routine scheduled checks no longer compete with ventricular fibrillation alerts in the same queue.
University of Chicago Medicine reviewed more than 73,000 reports annually through Rhythm360 in calendar year 2025, averaging more than 18,000 reports per quarter, with stable dismissal rates. This volume shows that high-volume monitoring remains manageable when alert triage is automated.
Practices using Rhythm360 have documented an 80% reduction in response times for critical alerts. Optional 24/7/365 oversight by certified cardiac technicians (CCTs) supervised by physicians adds another triage layer for high-volume or after-hours coverage.
Remote CIED monitoring generates billable events under several CPT codes. The most commonly missed include:
CMS remote patient monitoring coverage requirements specify documentation and transmission thresholds that must be met for reimbursement, and fragmented manual workflows often fail to capture the evidence trail needed to support these claims.
Rhythm360 automates CPT code documentation at the point of transmission review. The platform tracks billable events, generates compliant reports, and writes billing data back to the EHR without manual work. Practices have reported up to a 300% increase in revenue generation through improved CPT code capture and the addition of RPM service lines for heart failure and hypertension management.
Request a revenue impact review for your specific device population mix.
On-call clinicians need full access without returning to the office. Rhythm360’s HIPAA-compliant mobile application lets EPs, NPs, and device technicians review transmissions, sign reports, and coordinate care from any smartphone.
Security and HIPAA considerations for cardiac monitoring integrations with multiple CIED vendors require PHI transmission over encrypted channels, comprehensive audit logging, role-based access controls, and end-to-end business associate agreement (BAA) coverage. Rhythm360 satisfies each of these requirements natively, with full audit trails on every access event and communication logged within the patient record.
The practical result is straightforward. A critical arrhythmia flagged on a Saturday morning can be reviewed, triaged, and acted upon before Saturday afternoon, without the clinician returning to the office.
Rhythm360 integrates with Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health, and other systems via HL7. The full onboarding process, including EHR integration setup, typically takes from a few days to a few weeks.
Large enterprise EHRs such as Epic and Oracle Health/Cerner require rigorous certification processes involving security review and multi-stakeholder coordination before CIED data integrations can go live, with local tuning of HL7/FHIR interfaces adding further complexity. RhythmScience manages this process on behalf of the practice and reduces the burden on internal IT teams.
SaaS-based pricing scales with clinic size and platform usage and avoids the high upfront costs associated with legacy on-premise systems like Paceart.
What is CIED remote monitoring?
CIED remote monitoring is the process of transmitting data from a cardiac implantable electronic device, such as a pacemaker, ICD, CRT, or implantable loop recorder, to a clinical review portal without an in-person visit. Transmitted data includes device diagnostics, arrhythmia episodes, lead integrity measurements, and battery status. Clinicians review transmissions on a scheduled or alert-triggered basis and document findings for clinical and billing purposes.
How do clinics manage multi-vendor CIED populations?
Most clinics currently manage multi-vendor CIED populations by maintaining separate logins for each manufacturer portal, including Medtronic CareLink, Abbott Merlin.net, Boston Scientific LATITUDE, and Biotronik Home Monitoring. Staff manually retrieve data from each portal, reconcile it with the EHR, and generate documentation for billing. Vendor-neutral platforms like Rhythm360 replace this fragmented workflow by aggregating all manufacturer data into a single dashboard with automated EHR write-back and billing documentation.
What CPT codes apply to remote CIED monitoring, and how are they billed?
The primary CPT codes for remote CIED monitoring include 93298, which covers remote interrogation of a pacemaker or ICD system with physician review and report, and 93299, which covers remote interrogation of a subcutaneous cardiac rhythm monitor. For remote physiologic monitoring of chronic conditions like heart failure, 99454 applies to device supply with daily recording or programmed alert transmission per 30-day period, and 99457 applies to the first 20 minutes of clinical staff time per month. Compliant billing requires documented transmission review within CMS-defined timeframes. Rhythm360 automates the capture and documentation of these billable events to reduce claim rejections and revenue leakage.
How long does it take to implement a vendor-neutral CIED platform?
Rhythm360 implementation, including EHR integration with systems such as Epic, Cerner, or Athenahealth, typically takes from a few days to a few weeks depending on practice size and EHR configuration complexity. RhythmScience manages the integration process, including HL7/FHIR interface configuration and security review coordination, to minimize disruption to clinical operations during onboarding.
Can clinicians access CIED data securely from a mobile device?
Yes. Rhythm360 provides a HIPAA-compliant mobile application that allows electrophysiologists, NPs, PAs, and device technicians to review transmissions, sign reports, and coordinate care from any smartphone. The application uses encrypted PHI transmission, role-based access controls, and comprehensive audit logging to meet HIPAA security requirements. All communications and access events are logged within the patient record, which supports compliance documentation.
Fragmented manufacturer mobile CIED monitoring apps persist because each OEM built its ecosystem to support its own devices, not the operational reality of a mixed-brand clinic. The result is four alert queues, four documentation workflows, four billing gaps, and one overextended clinical team.
A unified platform must deliver vendor-neutral data ingestion, AI-powered alert triage, automated CPT documentation, HIPAA-compliant mobile access, and EHR integration that writes data back without manual work. Rhythm360 addresses each of these requirements and has demonstrated results at scale, including the volume handled at University of Chicago Medicine, dramatically faster critical response times, and substantial revenue growth for practices that consolidate onto a single platform.
The administrative and clinical cost of fragmentation is not a future risk. It is a present, measurable drain on every clinic managing more than one device manufacturer today.
